[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100570166":3},{"organization":4,"outcomesModule":7,"designInfo":20,"detailedDescription":19,"studyPopulation":19,"armGroups":29,"interventions":41,"overallOfficials":51,"centralContacts":56,"locations":66,"responsibleParty":84,"collaborators":19,"id":86,"slug":19,"hasResults":87,"nctId":88,"briefTitle":89,"officialTitle":90,"acronym":19,"eligibilityCriteria":91,"healthyVolunteers":92,"sex":93,"minAge":94,"maxAge":95,"enrollmentInfo":96,"targetDuration":19,"studyType":99,"phases":100,"briefSummary":102,"conditions":103,"keywords":19,"overallStatus":69,"whyStopped":19,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":114},{"fullName":5,"class":6},"JW Pharmaceutical","INDUSTRY",{"primaryOutcomes":8,"secondaryOutcomes":19,"otherOutcomes":19},[9,13,15,17],{"measure":10,"description":11,"timeFrame":12},"Area under the plasma drug concentration-time curve from 0 to last (AUClast) of JW2286","Pharmacokinetic Characteristics Evaluation","0 to 168 hours",{"measure":14,"description":11,"timeFrame":12},"Area under the plasma drug concentration-time curve from 0 to infinity (AUCinf) of JW2286",{"measure":16,"description":11,"timeFrame":12},"The maximum or peak concentration between zero and dosing interval (Cmax) of JW2286",{"measure":18,"description":11,"timeFrame":12},"Time of Maximum Concentration (Tmax) of JW2286",null,{"allocation":21,"interventionModel":22,"interventionModelDescription":19,"primaryPurpose":23,"observationalModel":19,"timePerspective":19,"maskingInfo":24},"RANDOMIZED","SEQUENTIAL","OTHER",{"masking":25,"maskingDescription":19,"whoMasked":26},"DOUBLE",[27,28],"PARTICIPANT","INVESTIGATOR",[30,36],{"label":31,"type":32,"description":33,"interventionNames":34},"Test group (JW2286)","EXPERIMENTAL","Ethnicity: Korean or Caucasian",[35],"Drug: JW2286",{"label":37,"type":38,"description":33,"interventionNames":39},"Placebo group (Placebo of JW2286)","PLACEBO_COMPARATOR",[40],"Drug: Placebo of JW2286",[42,47],{"type":43,"name":44,"description":45,"armGroupLabels":46,"otherNames":19},"DRUG","JW2286","a single administration of JW2286 per dose",[31],{"type":43,"name":48,"description":49,"armGroupLabels":50,"otherNames":19},"Placebo of JW2286","a single administration of Placebo of JW2286 per dose",[37],[52],{"name":53,"affiliation":54,"role":55},"SeungHwan Lee","Seoul National University Hospital","PRINCIPAL_INVESTIGATOR",[57,62],{"name":58,"role":59,"phone":60,"phoneExt":19,"email":61},"Hyeona Kim","CONTACT","+82-840-6791","hyeona.kim@jwhealthcare.com",{"name":63,"role":59,"phone":64,"phoneExt":19,"email":65},"Soojin Park","+82-2-840-6166","park.soojin@jwhealthcare.com",[67],{"facility":68,"status":69,"city":70,"state":19,"zip":19,"country":71,"countryCode":19,"cosmosGeoPoint":72,"geoPoint":77,"contacts":78},"Seoul National University Hospital Clinical Trial Center","RECRUITING","Seoul","South Korea",{"type":73,"coordinates":74},"Point",[75,76],126.9784,37.566,{"lat":76,"lon":75},[79,83],{"name":80,"role":59,"phone":81,"phoneExt":19,"email":82},"Jaegu Kang","+82-2072-1666","rkdworn489@snu.ac.kr",{"name":53,"role":59,"phone":19,"phoneExt":19,"email":19},{"type":85,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR","100570166",false,"NCT06703710","To Evaluate the Safety\u002FTolerability and Pharmacokinetic Characteristics in Healthy Volunteers","A Randomized, Double-blind, Placebo-controlled, Single Ascending Dose, Phase 1 Clinical Trial to Evaluate the Safety\u002FTolerability and PK Characteristics, and to Explore Food Effect and Ethnic Difference of JW2286 in Healthy Volunteers","Inclusion Criteria:\n\n* Healthy Korean or Caucasian volunteers\n\nExclusion Criteria:\n\n* Individuals with a clinically significant disease or history\n* Individuals with a history of a gastrointestinal disorder or surgery\n* In the case of all female individuals with childbearing potential, except for those who are surgically sterile",true,"ALL","19 Years","50 Years",{"count":97,"type":98},72,"ESTIMATED","INTERVENTIONAL",[101],"PHASE1","This clinical trial is a randomized, double-blind, placebo-controlled, single ascending dose, phase 1 clinical trial to evaluate the safety\u002Ftolerability and pharmacokinetic characteristics, and to explore food effect and ethnic difference of JW2286 after oral administration in healthy adults.",[104],"Healthy","2025-01-09",{"date":107,"type":108},"2025-01-13","ACTUAL",{"date":110,"type":108},"2025-01-06",{"date":112,"type":98},"2026-01",{"name":5,"class":6},1]